35 related articles for article (PubMed ID: 8217366)
1. Serum IgA to Epstein-Barr virus early antigen-diffuse identifies Hodgkin's lymphoma.
McAllister SC; Shedd D; Mueller NE; Chang ET; Miller G; Bhaduri-McIntosh S
J Med Virol; 2014 Sep; 86(9):1621-8. PubMed ID: 24122847
[TBL] [Abstract][Full Text] [Related]
2. Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis.
Huang J; Tengvall K; Bomfim Lima I; Hedström AK; Butt J; Brenner N; Gyllenberg A; Stridh P; Khademi M; Ernberg I; Al Nimer F; Manouchehrinia A; Hillert J; Alfredsson L; Andersen O; Sundström P; Waterboer T; Olsson T; Kockum I
Brain; 2024 Apr; ():. PubMed ID: 38630618
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications.
Bjornevik K; Münz C; Cohen JI; Ascherio A
Nat Rev Neurol; 2023 Mar; 19(3):160-171. PubMed ID: 36759741
[TBL] [Abstract][Full Text] [Related]
4. Possible Relations Between Epstein-Barr Virus Past Infection and Classic Multiple Sclerosis in Guilan, Iran.
Honarmand H; Ahmadi Jalali Moghadam M; Hatamian H; Roudbary A
Jundishapur J Microbiol; 2015 Jun; 8(6):e15985. PubMed ID: 26322199
[TBL] [Abstract][Full Text] [Related]
5. Investigation of epstein-barr virus as a potential cause of B-cell non-Hodgkin lymphoma in a prospective cohort.
De Roos AJ; Martínez-Maza O; Jerome KR; Mirick DK; Kopecky KJ; Madeleine MM; Magpantay L; Edlefsen KL; Lacroix AZ
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1747-55. PubMed ID: 23885038
[TBL] [Abstract][Full Text] [Related]
6. Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma.
Levin LI; Chang ET; Ambinder RF; Lennette ET; Rubertone MV; Mann RB; Borowitz M; Weir EG; Abbondanzo SL; Mueller NE
Blood; 2012 Nov; 120(18):3750-5. PubMed ID: 22972983
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus serologic abnormalities and risk of rheumatoid arthritis among women.
Goldstein BL; Chibnik LB; Karlson EW; Costenbader KH
Autoimmunity; 2012 Mar; 45(2):161-8. PubMed ID: 22011088
[TBL] [Abstract][Full Text] [Related]
8. Antibody titers against EBNA1 and EBNA2 in relation to Hodgkin lymphoma and history of infectious mononucleosis.
Mueller NE; Lennette ET; Dupnik K; Birmann BM
Int J Cancer; 2012 Jun; 130(12):2886-91. PubMed ID: 21805472
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma.
Bertrand KA; Birmann BM; Chang ET; Spiegelman D; Aster JC; Zhang SM; Laden F
Blood; 2010 Nov; 116(18):3547-53. PubMed ID: 20647565
[TBL] [Abstract][Full Text] [Related]
10. EBNA1 and LMP1 variants in multiple sclerosis cases and controls.
Simon KC; Yang X; Munger KL; Ascherio A
Acta Neurol Scand; 2011 Jul; 124(1):53-8. PubMed ID: 20636447
[TBL] [Abstract][Full Text] [Related]
11. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
Levin LI; Munger KL; O'Reilly EJ; Falk KI; Ascherio A
Ann Neurol; 2010 Jun; 67(6):824-30. PubMed ID: 20517945
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk.
Simon KC; van der Mei IA; Munger KL; Ponsonby A; Dickinson J; Dwyer T; Sundström P; Ascherio A
Neurology; 2010 Apr; 74(17):1365-71. PubMed ID: 20375311
[TBL] [Abstract][Full Text] [Related]
13. Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica.
Birmann BM; Breen EC; Stuver S; Cranston B; Martínez-Maza O; Falk KI; Okayama A; Hanchard B; Mueller N; Hisada M
Int J Cancer; 2009 Feb; 124(3):614-21. PubMed ID: 18989900
[TBL] [Abstract][Full Text] [Related]
14. Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease.
Cooper GS; Gilbert KM; Greidinger EL; James JA; Pfau JC; Reinlib L; Richardson BC; Rose NR
Environ Health Perspect; 2008 Jun; 116(6):695-702. PubMed ID: 18560522
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus and rheumatoid arthritis: is there a link?
Costenbader KH; Karlson EW
Arthritis Res Ther; 2006; 8(1):204. PubMed ID: 16542469
[TBL] [Abstract][Full Text] [Related]
16. Maintenance of serum immunoglobulin G antibodies to Epstein-Barr virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection.
Harada S; Kamata Y; Ishii Y; Eda H; Kitamura R; Obayashi M; Ito S; Ban F; Kuranari J; Nakajima H; Kuze T; Hayashi M; Okabe N; Senpuku H; Miyasaka N; Nakamura Y; Kanegane H; Yanagi K
Clin Diagn Lab Immunol; 2004 Jan; 11(1):123-30. PubMed ID: 14715558
[TBL] [Abstract][Full Text] [Related]
17. Anti-EBNA1/anti-EBNA2 ratio decreases significantly in patients with progression of HIV infection.
Winkelspecht B; Grässer F; Pees HW; Mueller-Lantzsch N
Arch Virol; 1996; 141(5):857-64. PubMed ID: 8678831
[TBL] [Abstract][Full Text] [Related]
18. Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6.
Lennette ET; Rymo L; Yadav M; Masucci G; Merk K; Timar L; Klein G
Eur J Cancer; 1993; 29A(11):1584-9. PubMed ID: 8217366
[TBL] [Abstract][Full Text] [Related]
19. Expression of Epstein-Barr virus nuclear antigen 1,2A and 2B in the baculovirus expression system: serological evaluation of human antibodies to these proteins.
Hille A; Klein K; Bäumler S; Grässer FA; Mueller-Lantzsch N
J Med Virol; 1993 Mar; 39(3):233-41. PubMed ID: 8385705
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
